5J2X
Crystal Structure of Hsp90-alpha N-domain in complex with 5-(5-Bromo-2,4-dihydroxy-phenyl)-4-(2-fluoro-phenyl)-2,4-dihydro-[1,2,4]triazol-3-one
5J2X の概要
エントリーDOI | 10.2210/pdb5j2x/pdb |
分子名称 | Heat shock protein HSP 90-alpha, 5-(5-Bromo-2,4-dihydroxy-phenyl)-4-(2-fluoro-phenyl)-2,4-dihydro-[1,2,4]triazol-3-one (3 entities in total) |
機能のキーワード | apo structure, chaperone |
由来する生物種 | Homo sapiens (Human) |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 23700.62 |
構造登録者 | |
主引用文献 | Amaral, M.,Kokh, D.B.,Bomke, J.,Wegener, A.,Buchstaller, H.P.,Eggenweiler, H.M.,Matias, P.,Sirrenberg, C.,Wade, R.C.,Frech, M. Protein conformational flexibility modulates kinetics and thermodynamics of drug binding. Nat Commun, 8:2276-2276, 2017 Cited by PubMed Abstract: Structure-based drug design has often been restricted by the rather static picture of protein-ligand complexes presented by crystal structures, despite the widely accepted importance of protein flexibility in biomolecular recognition. Here we report a detailed experimental and computational study of the drug target, human heat shock protein 90, to explore the contribution of protein dynamics to the binding thermodynamics and kinetics of drug-like compounds. We observe that their binding properties depend on whether the protein has a loop or a helical conformation in the binding site of the ligand-bound state. Compounds bound to the helical conformation display slow association and dissociation rates, high-affinity and high cellular efficacy, and predominantly entropically driven binding. An important entropic contribution comes from the greater flexibility of the helical relative to the loop conformation in the ligand-bound state. This unusual mechanism suggests increasing target flexibility in the bound state by ligand design as a new strategy for drug discovery. PubMed: 29273709DOI: 10.1038/s41467-017-02258-w 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.22 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード